Skip to main content

Table 1 Comparison of clinical characteristics

From: Usefulness of hemoglobin A1c and glycated albumin measurements for insulinoma screening: an observational case-control study

  Insulinoma group (n = 31) Control group (n = 120) P value
Male gender, n (%) 10 (32.3) 36 (30.0) 0.808
Age, years 58.3 ± 19.7 57.3 ± 3.0 0.608
BMI, kg/m2 24.4 ± 4.3 23.9 ± 2.2 0.390
FPG, mg/dL 51.3 ± 15.3 93.0 ± 6.2 < 0.001
Fasting IRI, μU/mL 17.0 ± 16.3 4.6 ± 2.1 < 0.001
Fasting IRI/FPG 0.380 ± 0.433 0.050 ± 0.022 < 0.001
HbA1c, % 4.7 ± 0.4 5.7 ± 0.3 < 0.001
GA, % 11.6 ± 1.8 14.5 ± 1.0 < 0.001
  1. Data are mean ± SD. BMI, body mass index; FPG, fasting plasma glucose; HbA1c, hemoglobin A1c; GA, glycate d albumin. P values are for differences between two groups